CDK5 and diabetes mellitus: It is clear from the vital research that CDK5 plays an important role in adipogenic diabetes and the inhibition of CDK5-mediated phosphorylation of PPARγ receptor could lead to the improvement in the serious side effects associated with the PPARγ agonists which may occur through their classical agonist actions.